<?xml version="1.0" encoding="UTF-8"?>

<PlanDefinition xmlns="http://hl7.org/fhir">
  <id value="HIVDT07"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: PlanDefinition</b><a name="HIVDT07"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PlanDefinition &quot;HIVDT07&quot; </p></div><p><b>url</b>: <code>http://fhir.org/guides/who/anc-cds/PlanDefinition/HIVDT07</code></p><p><b>identifier</b>: HIV.DT.07. (use: OFFICIAL)</p><p><b>version</b>: 0.3.0</p><p><b>name</b>: HIVDT07</p><p><b>title</b>: HIV.DT.07. Check for treatment failure</p><p><b>type</b>: ECA Rule <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.4.0/CodeSystem-plan-definition-type.html">PlanDefinitionType</a>#eca-rule)</span></p><p><b>status</b>: active</p><p><b>experimental</b>: false</p><p><b>date</b>: 2024-03-04 15:49:21+0300</p><p><b>publisher</b>: World Health Organization (WHO) </p><p><b>contact</b>: <a href="https://www.who.int">https://www.who.int</a></p><p><b>description</b>: &quot;HIV diagnosis = &quot;HIV positive&quot;
</p><h3>UseContexts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style="display: none">*</td><td>Workflow Task (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code task = 'Workflow Task', stated as 'Workflow Task')</td><td>Check for signs of treatment failure <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (activity-codes#HIV.D17.)</span></td></tr></table><p><b>jurisdiction</b>: Global (Whole world) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (m49.htm#001)</span></p><p><b>library</b>: <a href="Library-HIVDT07.html">HIV.DT.07. Check for treatment failure</a></p><blockquote><p><b>action</b></p><p><b>title</b>: HIV.DT.07. Check for treatment failure</p><h3>Triggers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Name</b></td></tr><tr><td style="display: none">*</td><td>named-event</td><td>HIV.D17. Check for signs of treatment failure</td></tr></table><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>1</blockquote><p><b>title</b>: Evaluate for virological failure.</p><p><b>description</b>: Evaluate for virological failure.</p><p><b>textEquivalent</b>: Viral load above 1000 copies/mL based on two consecutive viral load measurements three months apart, with adherence support following the first viral load test.  An individual must be taking ART for six months before it can be determined that a regimen has failed
An individual must be taking ART for six months before it can be determined that a regimen has failed Individuals with viral load &gt; 50 to &lt; 1000 copies, maintain ARV regimen, enhance adherence counselling and repeat viral load testing after three months. Consider switch after second viral load &gt; 50 to &lt; 1000 copies/mL if people are on NNRTI-based ART.</p><blockquote><p><b>documentation</b></p></blockquote><blockquote><p><b>condition</b></p></blockquote></blockquote><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>2</blockquote><p><b>title</b>: Evaluate for immunological failure</p><p><b>description</b>: Evaluate for immunological failure</p><p><b>textEquivalent</b>: Without concomitant or recent infection to cause a transient decline in the CD4 cell count
Current WHO clinical and immunological criteria have low sensitivity and positive predictive value for identifying individuals with virological failure. There is currently no proposed alternative definition of treatment failure and no validated alternative definition of immunological failure</p><blockquote><p><b>documentation</b></p></blockquote><blockquote><p><b>condition</b></p></blockquote></blockquote><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>3</blockquote><p><b>title</b>: Evaluate for clinical failure, including checking for 6 months of effective treatment.</p><p><b>description</b>: Evaluate for clinical failure, including checking for 6 months of effective treatment.</p><p><b>textEquivalent</b>: New or recurrent clinical event indicating severe immunodeficiency (WHO clinical stage 4 condition) after six months of effective treatment

The condition must be differentiated from immune reconstitution inflammatory syndrome occurring after initiating ART. For adults, certain WHO clinical stage 3 conditions (pulmonary TB and severe bacterial infections) may also indicate treatment failure.  </p><blockquote><p><b>documentation</b></p></blockquote><blockquote><p><b>condition</b></p></blockquote></blockquote><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>4</blockquote><p><b>title</b>: Evaluate for clinical failure, including checking for 6 months of effective treatment.</p><p><b>description</b>: Evaluate for clinical failure, including checking for 6 months of effective treatment. 2</p><p><b>textEquivalent</b>: New or recurrent clinical event indicating advanced or severe immunodeficiency (WHO clinical stage 3 and 4 clinical condition except for TB) after six months of effective treatment.  

The condition must be differentiated from immune reconstitution inflammatory syndrome occurring after initiating ART.  </p><blockquote><p><b>documentation</b></p></blockquote><blockquote><p><b>condition</b></p></blockquote></blockquote><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>5</blockquote><p><b>title</b>: Evaluate for clinical failure, including checking for 6 months of effective treatment and a clinical stage 3 condition other than TB.</p><p><b>description</b>: Evaluate for clinical failure, including checking for 6 months of effective treatment and a clinical stage 3 condition other than TB.</p><p><b>textEquivalent</b>: New or recurrent clinical event indicating advanced or severe immunodeficiency (WHO clinical stage 3 and 4 clinical condition except for TB) after six months of effective treatment.  

The condition must be differentiated from immune reconstitution inflammatory syndrome occurring after initiating ART.  </p><blockquote><p><b>documentation</b></p></blockquote><blockquote><p><b>condition</b></p></blockquote></blockquote></blockquote></div>
  </text>
  <url value="http://fhir.org/guides/who/anc-cds/PlanDefinition/HIVDT07"/>
  <identifier>
    <use value="official"/>
    <value value="HIV.DT.07."/>
  </identifier>
  <version value="0.3.0"/>
  <name value="HIVDT07"/>
  <title value="HIV.DT.07. Check for treatment failure"/>
  <type>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
      <code value="eca-rule"/>
    </coding>
  </type>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2024-03-04T15:49:21+03:00"/>
  <publisher value="World Health Organization (WHO) "/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="https://www.who.int"/>
    </telecom>
  </contact>
  <description value="&quot;HIV diagnosis = &quot;HIV positive&quot;&#xA;"/>
  <useContext>
    <code>
      <system value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
      <code value="task"/>
      <display value="Workflow Task"/>
    </code>
    <valueCodeableConcept>
      <coding>
        <system value="http://fhir.org/guides/who/anc-cds/CodeSystem/activity-codes"/>
        <code value="HIV.D17."/>
        <display value="Check for signs of treatment failure"/>
      </coding>
    </valueCodeableConcept>
  </useContext>
  <jurisdiction>
    <coding>
      <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
      <code value="001"/>
    </coding>
  </jurisdiction>
  <library value="http://fhir.org/guides/who/anc-cds/Library/HIVDT07"/>
  <action>
    <title value="HIV.DT.07. Check for treatment failure"/>
    <trigger>
      <type value="named-event"/>
      <name value="HIV.D17. Check for signs of treatment failure"/>
    </trigger>
    <action id="1">
      <title value="Evaluate for virological failure."/>
      <description value="Evaluate for virological failure."/>
      <textEquivalent value="Viral load above 1000 copies/mL based on two consecutive viral load measurements three months apart, with adherence support following the first viral load test.  An individual must be taking ART for six months before it can be determined that a regimen has failed&#xA;An individual must be taking ART for six months before it can be determined that a regimen has failed Individuals with viral load &gt; 50 to &lt; 1000 copies, maintain ARV regimen, enhance adherence counselling and repeat viral load testing after three months. Consider switch after second viral load &gt; 50 to &lt; 1000 copies/mL if people are on NNRTI-based ART."/>
      <documentation>
        <type value="citation"/>
        <label value="Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach (2021) &#xA;Table 4.11: WHO definitions of clinical, immunological and virological failure for the decision to switch ART regimens&#xA;&#xA;Note (from table 4.11, above): Current WHO clinical and immunological criteria have low sensitivity and positive predictive value for identifying individuals with virological failure. There is currently no proposed alternative definition of treatment failure and no validated alternative definition of immunological failure. Previous guidelines defined immunological failure based on a fall from baseline, which is no longer applicable in the context of CD4-independent treatment initiation. The option of CD4 cell count at 250 cells/mm3 following clinical failure is based on an analysis of data from Uganda and Zimbabwe.&#xA;&#xA;For WHO Clinical Stage conditions: &#xA;Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2nd ed. (2016). &#xA;Annex 10. WHO clinical staging of HIV disease in adults, adolescents and children."/>
      </documentation>
      <condition>
        <kind value="applicability"/>
        <expression>
          <description value="( &#xA;Age ≥ 10 years)&#xA;  AND (Visit date ≥ ART start date + 6 months)&#xA;  AND ( &#xA;Viral load test result = &gt; 1000 copies/ml)&#xA;  AND ( &#xA;Viral load test date  = &quot;Viral load test date&quot; a − &quot;Viral load test date&quot; b ≤  3 months)"/>
          <language value="text/cql-identifier"/>
          <expression value="Should Evaluate for virological failure."/>
        </expression>
      </condition>
    </action>
    <action id="2">
      <title value="Evaluate for immunological failure"/>
      <description value="Evaluate for immunological failure"/>
      <textEquivalent value="Without concomitant or recent infection to cause a transient decline in the CD4 cell count&#xA;Current WHO clinical and immunological criteria have low sensitivity and positive predictive value for identifying individuals with virological failure. There is currently no proposed alternative definition of treatment failure and no validated alternative definition of immunological failure"/>
      <documentation>
        <type value="citation"/>
      </documentation>
      <condition>
        <kind value="applicability"/>
        <expression>
          <description value="(((( &#xA;Age ≥ 10 years)&#xA;  AND ( &#xA;CD4 count ≤ 250 cells/mm3)&#xA;  AND ( &#xA;Treatment failure  = Clinical failure))&#xA;  OR (( &#xA;Age ≥ 10 years)&#xA;  AND ( &#xA;CD4 count ≤ 100 cells/mm3)))&#xA;  OR (( &#xA;Age ≥ 5 years and &lt; 10 years)&#xA;  AND ( &#xA;CD4 count  &lt; 100 cells/mm3)))&#xA;  OR (( &#xA;Age &lt; 5 years)&#xA;  AND ( &#xA;CD4 count &lt; 200 cells/mm3))"/>
          <language value="text/cql-identifier"/>
          <expression value="Should Evaluate for immunological failure"/>
        </expression>
      </condition>
    </action>
    <action id="3">
      <title value="Evaluate for clinical failure, including checking for 6 months of effective treatment."/>
      <description value="Evaluate for clinical failure, including checking for 6 months of effective treatment."/>
      <textEquivalent value="New or recurrent clinical event indicating severe immunodeficiency (WHO clinical stage 4 condition) after six months of effective treatment&#xA;&#xA;The condition must be differentiated from immune reconstitution inflammatory syndrome occurring after initiating ART. For adults, certain WHO clinical stage 3 conditions (pulmonary TB and severe bacterial infections) may also indicate treatment failure.  "/>
      <documentation>
        <type value="citation"/>
      </documentation>
      <condition>
        <kind value="applicability"/>
        <expression>
          <description value="((( &#xA;Age ≥ 10 years)&#xA;  AND ( &#xA;Clinical event type = WHO clinical stage 4 condition))&#xA;  OR (( &#xA;Age ≥ 10 years)&#xA;  AND (Visit date ≥ ART start date + 6 months)&#xA;  AND ( &#xA;Clinical event type = &quot;WHO clinical stage 3 condition&quot;)&#xA;  AND ( &#xA;WHO clinical stage symptoms = Pulmonary TB)))&#xA;  OR (( &#xA;Age ≥ 10 years)&#xA;  AND (Visit date ≥ ART start date + 6 months)&#xA;  AND ( &#xA;Clinical event type = &quot;WHO clinical stage 3 condition&quot;)&#xA;  AND ( &#xA;WHO clinical stage symptoms = Severe bacterial infections))"/>
          <language value="text/cql-identifier"/>
          <expression value="Should Evaluate for clinical failure, including checking for 6 months of effective treatment."/>
        </expression>
      </condition>
    </action>
    <action id="4">
      <title value="Evaluate for clinical failure, including checking for 6 months of effective treatment."/>
      <description value="Evaluate for clinical failure, including checking for 6 months of effective treatment. 2"/>
      <textEquivalent value="New or recurrent clinical event indicating advanced or severe immunodeficiency (WHO clinical stage 3 and 4 clinical condition except for TB) after six months of effective treatment.  &#xA;&#xA;The condition must be differentiated from immune reconstitution inflammatory syndrome occurring after initiating ART.  "/>
      <documentation>
        <type value="citation"/>
      </documentation>
      <condition>
        <kind value="applicability"/>
        <expression>
          <description value="( &#xA;Age &lt; 10 years)&#xA;  AND (Visit date ≥ ART start date + 6 months)&#xA;  AND ( &#xA;Clinical event type = &quot;WHO clinical stage 4 condition&quot;)"/>
          <language value="text/cql-identifier"/>
          <expression value="Should Evaluate for clinical failure, including checking for 6 months of effective treatment. 2"/>
        </expression>
      </condition>
    </action>
    <action id="5">
      <title value="Evaluate for clinical failure, including checking for 6 months of effective treatment and a clinical stage 3 condition other than TB."/>
      <description value="Evaluate for clinical failure, including checking for 6 months of effective treatment and a clinical stage 3 condition other than TB."/>
      <textEquivalent value="New or recurrent clinical event indicating advanced or severe immunodeficiency (WHO clinical stage 3 and 4 clinical condition except for TB) after six months of effective treatment.  &#xA;&#xA;The condition must be differentiated from immune reconstitution inflammatory syndrome occurring after initiating ART.  "/>
      <documentation>
        <type value="citation"/>
      </documentation>
      <condition>
        <kind value="applicability"/>
        <expression>
          <description value="( &#xA;Age &lt; 10 years)&#xA;  AND (Visit date ≥ ART start date + 6 months)&#xA;  AND ( &#xA;Clinical event type = &quot;WHO clinical stage 3 condition&quot;)"/>
          <language value="text/cql-identifier"/>
          <expression value="Should Evaluate for clinical failure, including checking for 6 months of effective treatment and a clinical stage 3 condition other than TB."/>
        </expression>
      </condition>
    </action>
  </action>
</PlanDefinition>